Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y T Chow

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Pharmaceutics|December 28, 2021
Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis TherapyZitong Shao, Waiting Tai, Yingshan Qiu, et al.
International Journal of Pharmaceutics|July 8, 2015
Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosisPhilip Chi Lip Kwok, Adam Grabarek, Michael Y T Chow, et al.
International Journal of Pharmaceutics|July 20, 2017
Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancerMichael Y T Chow, Yingshan Qiu, Fiona F K Lo, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 12, 2020
Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19Ahmed H Albariqi, Rachel Yoon Kyung Chang, Waiting Tai, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 5, 2022
The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in miceRachel Yoon Kyung Chang, Michael Y T Chow, Yuncheng Wang, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in MiceMichael Y T Chow, Rachel Yoon Kyung Chang, Mengyu Li, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 30, 2020
Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection modelYu Lin, Diana Quan, Rachel Yoon Kyung Chang, et al.
The Journal of Biological Chemistry|March 27, 1999
Cef1p is a component of the Prp19p-associated complex and essential for pre-mRNA splicingW Y Tsai, Y T Chow, H R Chen, et al.
Molecular Pharmaceutics|January 21, 2015
Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virusWanling Liang, Michael Y T Chow, Pui Ngan Lau, et al.
Scientific Reports|November 29, 2024
Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosisStephanie A Harker, Melissa Preissner, Rachel Yoon Chang, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Pharmaceutics|December 28, 2021
Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis TherapyZitong Shao, Waiting Tai, Yingshan Qiu, et al.
International Journal of Pharmaceutics|July 8, 2015
Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosisPhilip Chi Lip Kwok, Adam Grabarek, Michael Y T Chow, et al.
International Journal of Pharmaceutics|July 20, 2017
Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancerMichael Y T Chow, Yingshan Qiu, Fiona F K Lo, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 12, 2020
Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19Ahmed H Albariqi, Rachel Yoon Kyung Chang, Waiting Tai, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 5, 2022
The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in miceRachel Yoon Kyung Chang, Michael Y T Chow, Yuncheng Wang, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in MiceMichael Y T Chow, Rachel Yoon Kyung Chang, Mengyu Li, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 30, 2020
Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection modelYu Lin, Diana Quan, Rachel Yoon Kyung Chang, et al.
The Journal of Biological Chemistry|March 27, 1999
Cef1p is a component of the Prp19p-associated complex and essential for pre-mRNA splicingW Y Tsai, Y T Chow, H R Chen, et al.
Molecular Pharmaceutics|January 21, 2015
Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virusWanling Liang, Michael Y T Chow, Pui Ngan Lau, et al.
Scientific Reports|November 29, 2024
Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosisStephanie A Harker, Melissa Preissner, Rachel Yoon Chang, et al.
Pageof 4